GSK3B and cardiac hypertrophy: On the contrary, when NFAT is phosphorylated by glycogen synthase kinase-3β (GSK-3β), this makes it translocate from the nucleus to the cytosol and the signaling pathways of cardiac hypertrophy are inhibited (21).